Back to Search
Start Over
NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study.
- Source :
- Gynecological Endocrinology; December 2023, Vol. 39 Issue 1, p1-5, 5p
- Publication Year :
- 2023
-
Abstract
- To investigate safety and effectiveness of NOMAC-E2 and levonorgestrel-containing COCs (COC<subscript>LNG</subscript>) in users over 40. In this large, observational study, new users<superscript>1</superscript> of NOMAC-E2 and COC<subscript>LNG</subscript> were recruited in Europe, Australia, and Latin America and followed-up via questionnaires. Incidence of venous thromboembolism (VTE) was expressed as incidence rate (IR; events/10<superscript>4</superscript> women-years [WY]). Unintended pregnancy was expressed by the Pearl Index (PI; contraceptive failures/100 WY). Mood and weight changes were defined as mean changes in mood score and percentage of body weight. Overall, 7,762 NOMAC-E2 and 6,059 COC<subscript>LNG</subscript> users over 40 were followed-up. NOMAC-E2 showed no increased VTE risk compared to COC<subscript>LNG</subscript>; confirmed events: 5 NOMAC-E2 (IR 5.9; 95% CI, 1.9–13.7) vs 4 COC<subscript>LNG</subscript> (IR 5.9; 95% CI, 1.6–15.1). Unintended pregnancy did not differ substantially between cohorts; confirmed events: 4 NOMAC-E2 (PI 0.05; 95% CI, 0.01–0.13) vs 5 COC<subscript>LNG</subscript> (PI 0.08; 95% CI, 0.03–0.18). No differential effect on mood and weight was observed between cohorts. NOMAC-E2 can be considered a valid alternative to COC<subscript>LNG</subscript> in perimenopausal women. [ABSTRACT FROM AUTHOR]
- Subjects :
- ORAL contraceptives
UNPLANNED pregnancy
THROMBOEMBOLISM
BODY weight
CONTRACEPTION
Subjects
Details
- Language :
- English
- ISSN :
- 09513590
- Volume :
- 39
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Gynecological Endocrinology
- Publication Type :
- Academic Journal
- Accession number :
- 174390606
- Full Text :
- https://doi.org/10.1080/09513590.2023.2166032